Mechanism of 1α,25-dihydroxyvitamin D3-dependent repression of interleukin-12B

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 810-818

  Gynther, Petra ^a   Toropainen, Sari ^a   Matilainen, Juha M ^a   Seuter, Sabine ^b   Carlberg, Carsten ^a,b   Väisänen, Sami ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Chromatin; IL 12B; Inflammation; Transcription; VDR

Indexed keywords

CALCITRIOL; HISTONE DEACETYLASE 3; HISTONE H3; HISTONE H4; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; MESSENGER RNA; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; VITAMIN D RECEPTOR;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; INTERLEUKIN-12 SUBUNIT P40; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RETINOID X RECEPTORS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION INITIATION SITE; VITAMIN D;

EID: 79955646565     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.037     Document Type: Article

References (39)

1. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R.M., et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 1991, 146:3074-3081.
2. Louis S., Dutertre C.A., Vimeux L., Fery L., Henno L., Dicou S., Kahi S., Deveau C., Meyer L., Goujard C., Hosmalin A. IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection. J. Leukoc. Biol. 2010, 87:645-653.
3. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
4. Vandenbroeck K., Alloza I., Gadina M., Matthys P. Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J. Pharm. Pharmacol. 2004, 56:145-160.
5. Kikly K., Liu L., Na S., Sedgwick J.D. The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 2006, 18:670-675.
6. Seder R.A., Kelsall B.L., Jankovic D. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 1996, 157:2745-2748.
7. Lemire J.M. Immunomodulatory actions of 1, 25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 1995, 53:599-602.
8. Qi X.-P., Li P., Li G., Sun Z., Li J.-S. 1, 25-dihydroxyvitamin D3 regulates LPS-induced cytokine production and reduces mortality in rats. World J. Gastroenterol. 2008, 28:3897-3902.
9. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di Lucia P., Lang R., Sinigaglia F., Panina-Bordignon P. Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998, 101:252-262.
10. Tang J., Zhou J., Luger D., Zhu W., Silver P.B., Grajewski R.S., Su S.-B., Chan C.-C., Adorini L., Caspi R.R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 2009, 182:4624-4632.
11. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Rev. Rheumatol. 2008, 4:404-412.
12. Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221:1181-1183.
13. Overbergh L., Decallonne B., Valckx D., Verstuyf A., Depovere J., Laureys J., Rutgeerts O., Saint-Arnaud R., Bouillon R., Mathieu C. Identification and immune regulation of 25-hydroxyvitamin D-1α-hydroxylase in murine macrophages. Clin. Exp. Immunol. 2000, 120:139-146.
14. Noda M., Vogel R.L., Craig A.M., Prahl J., DeLuca H.F., Denhardt D.T. Identification of a DNA sequence responsible for binding of the 1, 25-dihydroxyvitamin D3 receptor and 1, 25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc. Natl Acad. Sci. USA 1990, 87:9995-9999.
15. Rhodes S.J., Chen R., DiMattia G.E., Scully K.M., Kalla K.A., Lin S.C., Yu V.C., Rosenfeld M.G. A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev. 1993, 7:913-932.
16. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell. Biol. 1995, 15:1154-1161.
17. Penna G., Adorini L. 1α, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
18. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-kB half-site. Mol. Cell. Biol. 1995, 15:5258-5267.
19. Plevy S.E., Gemberling J.H.M., Hsu S., Dorner A.J., Smale S.T. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 1997, 17:4572-4588.
20. Zhu C., Gagnidze K., Gemberling J.H.M., Plevy S.E. Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. J. Biol. Chem. 2001, 276:18519-18528.
21. 3 on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 2010, 1803:1276-1286.
22. Podvinec M., Kaufmann M.R., Handschin C., Meyer U.A. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol. Endocrinol. 2002, 16:1269-1279.
23. 3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J. Immunol. 2005, 174:2061-2070.
24. Matilainen J.M., Räsänen A., Gynther P., Väisänen S. The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1α, 25(OH)2D3 target genes. J. Steroid Biochem. Mol. Biol. 2010, 121:142-145.
25. Weinmann A.S., Plevy S.E., Smale S.T. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 1999, 11:665-675.
26. Saramäki A., Diermeier S., Kellner R., Laitinen H., Väisänen S., Carlberg C. Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1α, 25-dihydroxyvitamin D3. J. Biol. Chem. 2009, 284:8073-8082.
27. Matilainen J.M., Malinen M., Turunen M.M., Carlberg C., Väisänen S. The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J. Biol. Chem. 2010, 285:24174-24183.
28. Toropainen S., Väisänen S., Heikkinen S., Carlberg C. The down-regulation of the human MYC gene by the nuclear hormone 1α, 25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol. 2010, 400:284-294.
29. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002, 195:603-616.
30. Heine G., Niesner U., Chang H.D., Steinmeyer A., Zügel U., Zuberbier T., Radbruch A., Worm M. 1, 25-dihydroxyvitamin D3 promotes IL-10 production in human B cells. Eur. J. Immunol. 2008, 38:2210-2218.
31. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D.J., Kastelein R.A., Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 2006, 116:1310-1316.
32. Damsker J.M., Hansen A.M., Caspi R.R. Th1 and Th17 cells: adversaries and collaborators. Ann. NY Acad. Sci. 2010, 1183:211-221.
33. Paradowska-Gorycka A., Grzybowska-Kowalczyk A., Wojtecka-Lukasik E., Maslinski S. IL-23 in the pathogenesis of rheumatoid arthritis. Scand. J. Immunol. 2010, 71:134-145.
34. Ahern P.P., Schiering C., Buonocore S., McGeachy M.J., Cua D.J., Maloy K.J., Powrie F. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010, 33:279-288.
35. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L.J., Grippo J.F., Hunziker W. Two nuclear signalling pathways for vitamin D. Nature 1993, 361:657-660.
36. Malinen M., Ryynänen J., Heinäniemi M., Väisänen S., Carlberg C. Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1α, 25-dihydroxyvitamin D3. Nucleic Acids Res. 2011, 39:502-512.
37. Sanchez-Martinez R., Zambrano A., Castillo A.I., Aranda A. Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol. Cell. Biol. 2008, 28:3817-3829.
38. Tagami T., Lutz W.H., Kumar R., Jameson J.L. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem. Biophys. Res. Commun. 1998, 253:358-363.
39. Roh T.-Y., Cuddapah S., Cui K., Zhao K. The genomic landscape of histone modifications in human T cells. PNAS 2006, 15782-15787.